AMCP 2024 Meeting Kicks Off in New Orleans | AMCP 2024
This week, the annual meeting of the Academy of Managed Care Pharmacy (AMCP) will bring 3,400 pharmacy, payers and industry leaders to New Orleans.
About 3,400 are expected to attend AMCP 2024, the annual meeting of the Academy of Managed Care Pharmacy from April 15, 2024, to April 18, 2024, at the Ernest N. Morial Convention Center in New Orleans.
The meeting will offer health plans, pharmacy benefit managers and others in managed care pharmacy educational sessions, poster presentations, an Expo with 75 exhibitors, and opportunities for networking. The AMCP Partnering, a mobile scheduling app, will allow attendees to connect with others. This year, the AMCP is offering a virtual photo booth, interactive mosaic for attendees to post selfies, and celebrating managed care pharmacy with the MCP Superpower Challenge.
A highlight will be the opening general session, which features the football-player-turned-magician Jon Dorenbos. He will perform magic for the AMCP audience, but also will tell personal stories, including about the heart surgery in 2017 that ended his football career. Dorenbos played 14 seasons in the NFL mostly for the Philadelphia Eagles and finishing with the New Orleans Saints.
After being traded to the Saints, Dorenbros was found to have an aortic aneurysm, a bulge in the aorta, which results in almost 10,000 deaths in 2019, according to the CDC. He underwent surgery to repair the aneurysm. Dorenbros will discuss his journey through the healthcare system.
There will also be three keynote presentations. One will feature Omar Ali, BSc, a visiting professor at University of Portsmouth in Woking, England. Ali will talk about value-based pricing and innovative contracting. He will discuss trends in the United States and globally, providing case studies and a look at what the future landscape for contracting could look like.
A second keynote will feature Doug M. Long from IQVIA, who will talk about healthcare and pharmaceutical marketplace trends. Long will also provide some predictions on coming trends in the industry. A third keynote will provide an update on the specialty pipeline from Jeffrey Casberg, R.Ph., and Lesli Fish, R.Ph., Pharm.D.
As published in JCMP, AMCP announced also announced update 5.0 for clinical and economic information and evidence. The format provides a framework for evidence and information presented to healthcare decision makers. The updated version address pre-approval information exchange, digital therapeutics, real-world evidence and health disparities.
Emerging Therapies Committee at UC Davis Hits the Accelerator Not the Brake | AMCP 2024
April 18th 2024After the onboarding of cell and gene therapy bogged using normal pharmacy and therapeutics (P&T) committee procedures, UC Davis Health set up an emerging therapeutics committee to streamline and speed up the process of delivery expensive cell and gene therapies.
Read More
Potential Generics Could Lower Prices for Oncology, Cardiovascular Drugs | AMCP 2024
April 18th 2024Up to 50 generics could be approved this year, including Victoza to treat patients with diabetes. If generics of Victoza become available, this would the first GLP-1 to face generic competition.
Read More
Are Value-Based Contracts the Answer to Ultra-High-Priced Gene Therapies? | AMCP 2024
April 17th 2024Innovative contracts are becoming more common for gene therapies. They aim to balance a therapy’s cost-effectiveness and affordability, as well as address the uncertainty of long-term benefit.
Read More
